{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:03:48Z","timestamp":1794269028439,"version":"4.9.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009169","name":"Assiut University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009169","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>To describe various demographic, clinical, laboratory, and capillaroscopic features of Egyptian patients with systemic sclerosis (SSc) and to explore the relation between various capillaroscopic features and internal organ involvement as well as other disease parameters. In this cross-sectional multi-centric prospective analysis, two hundred twenty-two adult patients with SSc were recruited. Data regarding general and rheumatological examination including the modified Rodnan skin score (MRSS), internal organ involvement and related imaging and laboratory investigations were collected. Both activity and severity indices were measured. Nail fold capillary microscopy (NFC) was performed for 144 patients. Out of 222 patients; 139 (62.6%) had limited type while 83 (37.4%) had diffuse type, middle aged females were predominant (91%). Peripheral vascular, pulmonary, gastrointestinal and general manifestations were the most frequently documented affection with high activity, severity profiles and bad prognostic features in more than half of the patients. MRSS was above 20 in 122 patients (55%), and 126 patients (56.8%) had pulmonary hypertension (SPAP) while 78.4% had ILD which showed a weak correlation to age and disease duration (r\u2009=\u20090.135, r\u2009=\u2009\u2212\u20090.152 respectively). Significant weak correlations were found between disease duration and SPAP (r\u2009=\u20090.134), Medseger\u2019s severity score (r\u2009=\u20090.189), peripheral vascular, skin, and GIT affection severity (r\u2009=\u20090.210, 0.135, and 0.196 respectively). Significant difference was observed between different NFC patterns and antibodies, severity scale, some disease manifestations i.e.: general, gastrointestinal, myopathy, and digital ulceration while no significance was found between NFC patterns and the type of SSc. This study provided a comprehensive clinical and laboratory characterization of a large cohort of Egyptian patients with SSc which reflects a more severe disease with unfavorable prognostic aspects compared to the available world-wide reports. Nail fold capillaroscopy showed many associations to different aspects of the disease especially in late and active capillaroscopic features, if introduced early, it may improve the disease outcome.<\/jats:p>","DOI":"10.1038\/s41598-025-14434-w","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T18:58:40Z","timestamp":1755629920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Systemic sclerosis in Egyptian population with emphasis on clinical and nailfold capillaroscopic features"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3903-3864","authenticated-orcid":false,"given":"Amira","family":"Elsonbaty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2945-2049","authenticated-orcid":false,"given":"Manal","family":"Hassanien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7291-3616","authenticated-orcid":false,"given":"Abdelhfeez","family":"Moshrif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7016-2863","authenticated-orcid":false,"given":"AbdelAzeim","family":"Elhefny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-0491","authenticated-orcid":false,"given":"Gihan M.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel M.","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-8864","authenticated-orcid":false,"given":"Mervat","family":"Abo Gabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3254-9289","authenticated-orcid":false,"given":"Hatem M.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9023-0509","authenticated-orcid":false,"given":"Rasha A.","family":"Abdel-Magied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7949-5098","authenticated-orcid":false,"given":"Sameh","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6614-8217","authenticated-orcid":false,"given":"Mahmoud I.","family":"Risha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1256-0588","authenticated-orcid":false,"given":"Hesham","family":"Hamoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"14434_CR1","unstructured":"Avina-Zubieta, J. A., Sayre, E. C., Bernatsky, S., Lehman, A. J., Shojania, K., Esdaile, J. et al. eds. Adult Prevalence of Systemic Autoimmune Rheumatic Diseases (SARDs) in British Columbia, Canada. Arthritis and Rheumatism. (Wiley-Blackwell, 2011)."},{"key":"14434_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2147\/CLEP.S191418","volume":"11","author":"A Bergamasco","year":"2019","unstructured":"Bergamasco, A., Hartmann, N., Wallace, L. & Verpillat, P. Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease. Clin. Epidemiol. 11, 257\u2013273 (2019).","journal-title":"Clin. Epidemiol."},{"issue":"6","key":"14434_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.5114\/reum.2016.64906","volume":"54","author":"K Romanowska-Pr\u00f3chnicka","year":"2016","unstructured":"Romanowska-Pr\u00f3chnicka, K., Walczyk, M. & Olesi\u0144ska, M. Recognizing systemic sclerosis: Comparative analysis of various sets of classification criteria. Reumatologia\/Rheumatology 54(6), 296\u2013305 (2016).","journal-title":"Reumatologia\/Rheumatology"},{"issue":"1","key":"14434_CR4","first-page":"1","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore, Y. et al. Systemic sclerosis. Nat. Rev. Disease Primers 1(1), 1\u201321 (2015).","journal-title":"Nat. Rev. Disease Primers"},{"issue":"1","key":"14434_CR5","first-page":"18","volume":"41","author":"M Cutolo","year":"2016","unstructured":"Cutolo, M., Sulli, A., Pizzorni, C., Paolino, S. & Smith, V. Systemic sclerosis: markers and targeted treatments. Acta Reumatol. Port. 41(1), 18\u201325 (2016).","journal-title":"Acta Reumatol. Port."},{"key":"14434_CR6","doi-asserted-by":"crossref","unstructured":"Jaeger Veronika, K., Wirz Elina, G., Allanore, Y., Rossbach, P., Riemekasten, G., Hachulla, E. et al. Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: A longitudinal EUSTAR study. (2016).","DOI":"10.1371\/journal.pone.0163894"},{"key":"14434_CR7","doi-asserted-by":"crossref","unstructured":"Maricq, H. R. & Carwile LeRoy, E. Rheumatology ROJotACo. Patterns of finger capillary abnormalities in connective tissue disease by \u201cwide\u2010field\u201d microscopy. 16(5), 619\u201328 (1973).","DOI":"10.1002\/art.1780160506"},{"issue":"1","key":"14434_CR8","first-page":"155","volume":"27","author":"M Cutolo","year":"2000","unstructured":"Cutolo, M., Sulli, A., Pizzorni, C. & Accardo, S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J. Rheumatol. 27(1), 155\u2013160 (2000).","journal-title":"J. Rheumatol."},{"issue":"2","key":"14434_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/2397198318757699","volume":"3","author":"B Ruaro","year":"2018","unstructured":"Ruaro, B. et al. Advances in nailfold capillaroscopic analysis in systemic sclerosis. J. Scleroderma Relat. Disorders 3(2), 122\u2013131 (2018).","journal-title":"J. Scleroderma Relat. Disorders"},{"issue":"Suppl 1","key":"14434_CR10","doi-asserted-by":"publisher","first-page":"e000782","DOI":"10.1136\/rmdopen-2018-000782","volume":"4","author":"V Smith","year":"2019","unstructured":"Smith, V. et al. Systemic sclerosis: State of the art on clinical practice guidelines. RMD Open 4(Suppl 1), e000782 (2019).","journal-title":"RMD Open"},{"issue":"7","key":"14434_CR11","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1093\/rheumatology\/kez486","volume":"59","author":"VK Jaeger","year":"2020","unstructured":"Jaeger, V. K. et al. Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study. Rheumatology 59(7), 1684\u20131694 (2020).","journal-title":"Rheumatology"},{"key":"14434_CR12","unstructured":"Cutolo M, Milan. Capillaroscopy links to clinical pathological issues in systemic sclerosis. 173\u20139 (2010)."},{"issue":"10","key":"14434_CR13","first-page":"1636","volume":"71","author":"V Smith","year":"2012","unstructured":"Smith, V. et al. Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement?. A pilot study. 71(10), 1636\u20131639 (2012).","journal-title":"A pilot study."},{"issue":"8","key":"14434_CR14","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/art.11073","volume":"48","author":"MD Mayes","year":"2003","unstructured":"Mayes, M. D. et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. Off. J. Am. Coll. Rheumatol. 48(8), 2246\u20132255 (2003).","journal-title":"Arthritis Rheum. Off. J. Am. Coll. Rheumatol."},{"issue":"9","key":"14434_CR15","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1093\/rheumatology\/keh253","volume":"43","author":"V Le Guern","year":"2004","unstructured":"Le Guern, V. et al. Prevalence of systemic sclerosis in a French multi-ethnic county. Rheumatology 43(9), 1129\u20131137 (2004).","journal-title":"Rheumatology"},{"key":"14434_CR16","doi-asserted-by":"crossref","unstructured":"Mulla, E., Shaffu, S., Hassan, W. AB0689 A Comparative Study of the Difference in Clinical Manifestations and Disease Outcomes Between South Asian and Caucasian Patients with Systemic Sclerosis in a Large NHS Trust, Within the United Kingdom. (BMJ Publishing Group Ltd, 2015).","DOI":"10.1136\/annrheumdis-2015-eular.1996"},{"issue":"11","key":"14434_CR17","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Van Den Hoogen","year":"2013","unstructured":"Van Den Hoogen, F. et al. 2013 classification criteria for systemic sclerosis: An American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum. 65(11), 2737\u20132747 (2013).","journal-title":"Arthritis Rheum."},{"issue":"7","key":"14434_CR18","first-page":"1281","volume":"22","author":"P Clements","year":"1995","unstructured":"Clements, P. et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J. Rheumatol. 22(7), 1281\u20131285 (1995).","journal-title":"J. Rheumatol."},{"issue":"9","key":"14434_CR19","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1136\/ard.62.9.901","volume":"62","author":"G Valentini","year":"2003","unstructured":"Valentini, G. et al. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Annals Rheum. Diseases 62(9), 901\u2013903 (2003).","journal-title":"Annals Rheum. Diseases"},{"issue":"10","key":"14434_CR20","first-page":"2159","volume":"26","author":"T Medsger Jr","year":"1999","unstructured":"Medsger, T. Jr. et al. A disease severity scale for systemic sclerosis: development and testing. J. Rheumatol. 26(10), 2159\u20132167 (1999).","journal-title":"J. Rheumatol."},{"key":"14434_CR21","unstructured":"Hao, Y., Hudson, M., Carreira, P., Stevens, W., Rabusa, C. & Tatibouet, S. et al. Early mortality in Australian, Canadian and Spanish scleroderma patients: rationale for establishing a multi-national inception cohort of patients with systemic sclerosis. (2014)."},{"issue":"2","key":"14434_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/23971983221145788","volume":"8","author":"R Namas","year":"2023","unstructured":"Namas, R. et al. Comprehensive description of the prevalence, serological and clinical characteristics, and visceral involvement of systemic sclerosis (scleroderma) in a large cohort from the United Arab Emirates Systemic Sclerosis Registry. J. Scleroderma Relat. Disorders 8(2), 137\u2013150 (2023).","journal-title":"J. Scleroderma Relat. Disorders"},{"issue":"4","key":"14434_CR23","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1378\/chest.12-2396","volume":"144","author":"NF Chaisson","year":"2013","unstructured":"Chaisson, N. F. & Hassoun, P. M. J. C. Systemic sclerosis-associated pulmonary arterial hypertension. Chest 144(4), 1346\u20131356 (2013).","journal-title":"Chest"},{"key":"14434_CR24","unstructured":"Parker, M. J. & McGill, N.W. The established and evolving role of nailfold capillaroscopy in connective-tissue disease. Connective Tissue Disease-Current State of the Art: IntechOpen (2018)."},{"issue":"2","key":"14434_CR25","first-page":"269","volume":"33","author":"B Chang","year":"2006","unstructured":"Chang, B., Schachna, L., White, B., Wigley, F. M. & Wise, R. A. Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma. J. Rheumatol. 33(2), 269\u2013274 (2006).","journal-title":"J. Rheumatol."},{"key":"14434_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4103\/1110-161X.123789","volume":"40","author":"RR Elshereef","year":"2013","unstructured":"Elshereef, R. R., Hassan, A. A., Darwish, A. F., Asklany, H. T. & Hamdy, L. Pulmonary hypertension in scleroderma and its relation to disease activity. Egypt. Rheumatol. Rehabil. 40, 173\u2013180 (2013).","journal-title":"Egypt. Rheumatol. Rehabil."},{"issue":"2","key":"14434_CR27","doi-asserted-by":"publisher","first-page":"920","DOI":"10.21608\/ejhm.2020.103657","volume":"80","author":"RM Hammoda","year":"2020","unstructured":"Hammoda, R. M., Ali, Y. A. & Samy, N. Value of nailfold capillaroscopy as a screening method for pulmonary arterial hypertension in patients with systemic sclerosis. Egypt. J. Hosp. Med. 80(2), 920\u2013927 (2020).","journal-title":"Egypt. J. Hosp. Med."},{"issue":"6","key":"14434_CR28","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/ard.2006.062901","volume":"66","author":"U Walker","year":"2007","unstructured":"Walker, U. et al. Clinical risk assessment of organ manifestations in systemic sclerosis: A report from the EULAR Scleroderma Trials and Research group database. Annals Rheum. Diseases 66(6), 754\u2013763 (2007).","journal-title":"Annals Rheum. Diseases"},{"issue":"3","key":"14434_CR29","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/ard.2010.136929","volume":"70","author":"J Avouac","year":"2011","unstructured":"Avouac, J. et al. Preliminary criteria for the very early diagnosis of systemic sclerosis: Results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Annals Rheum. Diseases 70(3), 476\u2013481 (2011).","journal-title":"Annals Rheum. Diseases"},{"issue":"2","key":"14434_CR30","first-page":"286","volume":"31","author":"M Bredemeier","year":"2004","unstructured":"Bredemeier, M. et al. Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis. J. Rheumatol. 31(2), 286\u2013294 (2004).","journal-title":"J. Rheumatol."},{"issue":"suppl_4","key":"14434_CR31","doi-asserted-by":"publisher","first-page":"iv43","DOI":"10.1093\/rheumatology\/kel310","volume":"45","author":"M Cutolo","year":"2006","unstructured":"Cutolo, M., Sulli, A., Secchi, M., Paolino, S. & Pizzorni, C. J. R. Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement?. Rheumatology 45(suppl_4), iv43\u2013iv46 (2006).","journal-title":"Rheumatology"},{"key":"14434_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s10067-005-0041-0","volume":"25","author":"P Ostoji\u0107","year":"2006","unstructured":"Ostoji\u0107, P. & Damjanov, N. Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis. Clin. Rheumatol. 25, 453\u2013457 (2006).","journal-title":"Clin. Rheumatol."},{"issue":"10","key":"14434_CR33","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/rheumatology\/kem190","volume":"46","author":"P Caramaschi","year":"2007","unstructured":"Caramaschi, P. et al. Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity. Rheumatology 46(10), 1566\u20131569 (2007).","journal-title":"Rheumatology"},{"key":"14434_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.mvr.2013.06.003","volume":"89","author":"F Ingegnoli","year":"2013","unstructured":"Ingegnoli, F. et al. Nailfold capillaroscopy in systemic sclerosis: data from the EULAR scleroderma trials and research (EUSTAR) database. Microvasc. Res. 89, 122\u2013128 (2013).","journal-title":"Microvasc. Res."},{"issue":"1","key":"14434_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5114\/reum.2017.66683","volume":"55","author":"S Shenavandeh","year":"2017","unstructured":"Shenavandeh, S., Haghighi, M. Y. & Nazarinia, M. A. J. R. R. Nailfold digital capillaroscopic findings in patients with diffuse and limited cutaneous systemic sclerosis. Reumatologia\/Rheumatology 55(1), 23\u201331 (2017).","journal-title":"Reumatologia\/Rheumatology"},{"key":"14434_CR36","doi-asserted-by":"crossref","unstructured":"Paxton, D. & Pauling, J. D. eds. Does Nailfold Capillaroscopy Help Predict Future Outcomes in Systemic Sclerosis? A Systematic Literature Review. Seminars in Arthritis and Rheumatism (Elsevier, 2018).","DOI":"10.1016\/j.semarthrit.2018.02.005"},{"issue":"6","key":"14434_CR37","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/rheumatology\/keh156","volume":"43","author":"M Cutolo","year":"2004","unstructured":"Cutolo, M. et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 43(6), 719\u2013726 (2004).","journal-title":"Rheumatology"},{"key":"14434_CR38","doi-asserted-by":"crossref","unstructured":"Kenik, J. G., Maricq, H. R. & Bole, G. G. Rheumatology ROJotACo. Blind evaluation of the diagnostic specificity of nailfold capillary microscopy in the connective tissue diseases. 24(7), 885\u201391 (1981).","DOI":"10.1002\/art.1780240704"},{"key":"14434_CR39","doi-asserted-by":"crossref","unstructured":"Sebastiani, M., Manfredi, A., Colaci, M., D\u2019amico, R., Malagoli, V. & Giuggioli, D. et al. Capillaroscopic skin ulcer risk index: A new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 61(5), 688-94 (2009).","DOI":"10.1002\/art.24394"},{"issue":"1","key":"14434_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/annrheumdis-2011-200022","volume":"71","author":"M Sebastiani","year":"2012","unstructured":"Sebastiani, M. et al. Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study. Annals Rheum. Diseases 71(1), 67\u201370 (2012).","journal-title":"Annals Rheum. Diseases"},{"issue":"2 Suppl 76","key":"14434_CR41","first-page":"115","volume":"31","author":"M Sebastiani","year":"2013","unstructured":"Sebastiani, M. et al. Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change. Clin. Exp. Rheumatol. 31(2 Suppl 76), 115\u2013117 (2013).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"14434_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3233\/CH-141809","volume":"59","author":"A Manfredi","year":"2015","unstructured":"Manfredi, A. et al. Prediction risk chart for scleroderma digital ulcers: a composite predictive model based on capillaroscopic, demographic and clinico-serological parameters. Clin. Hemorheol. Microcirc. 59(2), 133\u2013143 (2015).","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"10","key":"14434_CR43","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1002\/art.39718","volume":"68","author":"M Cutolo","year":"2016","unstructured":"Cutolo, M. et al. Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: A multicenter, prospective cohort study. Arthritis Rheumatol. 68(10), 2527\u20132539 (2016).","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"14434_CR44","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1093\/rheumatology\/ket168","volume":"52","author":"V Riccieri","year":"2013","unstructured":"Riccieri, V. et al. Systemic sclerosis patients with and without pulmonary arterial hypertension: A nailfold capillaroscopy study. Rheumatology 52(8), 1525\u20131528 (2013).","journal-title":"Rheumatology"},{"issue":"3","key":"14434_CR45","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1378\/chest.120.3.796","volume":"120","author":"EL Greidinger","year":"2001","unstructured":"Greidinger, E. L. et al. Primary pulmonary hypertension is not associated with scleroderma-like changes in nailfold capillaries. Chest 120(3), 796\u2013800 (2001).","journal-title":"Chest"},{"key":"14434_CR46","doi-asserted-by":"crossref","unstructured":"Reyes-Rueda, J., Gutierrez-Ure\u00f1a, S., Gonzalez-D\u00edaz, V., Mart\u00ednez-Bonilla, G., Garcia-Osuna, K. & Cardona-Muller, D. et al. AB0771 Abnormal Capillaroscopy and Pulmonary Hypertension in Patients with Systemic Sclerosis. (BMJ Publishing Group Ltd, 2018).","DOI":"10.1136\/annrheumdis-2018-eular.6133"},{"issue":"2\u20133","key":"14434_CR47","first-page":"81","volume":"16","author":"YY Ong","year":"1998","unstructured":"Ong, Y. Y. et al. Decreased nailfold capillary density in limited scleroderma with pulmonary hypertension. J. Allergy Immunol. 16(2\u20133), 81 (1998).","journal-title":"J. Allergy Immunol."},{"issue":"2","key":"14434_CR48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/ard.2007.087353","volume":"68","author":"H Hofstee","year":"2009","unstructured":"Hofstee, H. et al. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis. Annals Rheum. Diseases. 68(2), 191\u2013195 (2009).","journal-title":"Annals Rheum. Diseases."},{"issue":"114","key":"14434_CR49","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mvr.2017.06.005","volume":"1","author":"A Corrado","year":"2017","unstructured":"Corrado, A. et al. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension. Microvasc. Res. 1(114), 46\u201351 (2017).","journal-title":"Microvasc. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14434-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14434-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14434-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T07:25:59Z","timestamp":1757402759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14434-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14434"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14434-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30456"}}